139 related articles for article (PubMed ID: 20478813)
1. [Punishment or benefit: chemical castration].
Gyuris J
Orv Hetil; 2010 May; 151(22):907-10. PubMed ID: 20478813
[No Abstract] [Full Text] [Related]
2. Chemical castration and anti-androgens induce differential gene expression in prostate cancer.
Lehmusvaara S; Erkkilä T; Urbanucci A; Waltering K; Seppälä J; Larjo A; Tuominen VJ; Isola J; Kujala P; Lähdesmäki H; Kaipia A; Tammela TLj; Visakorpi T
J Pathol; 2012 Jul; 227(3):336-45. PubMed ID: 22431170
[TBL] [Abstract][Full Text] [Related]
3. [Care of sexual offenders. Only pharmacologic treatment is effective].
Eriksson T
Lakartidningen; 1994 Oct; 91(40):3611-4, 3617. PubMed ID: 7990604
[No Abstract] [Full Text] [Related]
4. Chemical castration for sex offenders.
Grubin D; Beech A
BMJ; 2010 Jan; 340():c74. PubMed ID: 20068060
[No Abstract] [Full Text] [Related]
5. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
Matveev BP; Bukharkin BV
Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710
[TBL] [Abstract][Full Text] [Related]
6. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
7. Controversies in the management of advanced prostate cancer.
Tyrrell CJ
Br J Cancer; 1999 Jan; 79(1):146-55. PubMed ID: 10408706
[TBL] [Abstract][Full Text] [Related]
8. Intermittent androgen deprivation therapy: clarity from confusion.
Klotz L
Eur Urol; 2013 Nov; 64(5):731-3. PubMed ID: 23866956
[No Abstract] [Full Text] [Related]
9. Androgen deprivation therapy and prostate cancer duration.
Williams SG; Pickles T; Buyyounouski MK
J Clin Oncol; 2009 Dec; 27(34):e228; author reply e229. PubMed ID: 19884533
[No Abstract] [Full Text] [Related]
10. Did you say chemical castration?
Bund JM
Univ Pittsbg Law Rev; 1997; 59(1):157-92. PubMed ID: 14631990
[No Abstract] [Full Text] [Related]
11. New therapies for castration-resistant prostate cancer: efficacy and safety.
Beltran H; Beer TM; Carducci MA; de Bono J; Gleave M; Hussain M; Kelly WK; Saad F; Sternberg C; Tagawa ST; Tannock IF
Eur Urol; 2011 Aug; 60(2):279-90. PubMed ID: 21592649
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer--management of disseminated disease (intermittent androgen suppression).
Lobel B; Richard F
Acta Chir Iugosl; 2005; 52(4):11-2. PubMed ID: 16673586
[No Abstract] [Full Text] [Related]
13. Maximal androgen blockade for advanced prostate cancer.
Klotz L
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):331-40. PubMed ID: 18471790
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis in men.
Galus M
Arch Intern Med; 1998 Jan; 158(2):194. PubMed ID: 9448564
[No Abstract] [Full Text] [Related]
15. [Advanced prostatic carcinoma--which hormone therapy when?].
Studer UE
Urologe A; 1995 Sep; 34(5):361-6. PubMed ID: 7483151
[No Abstract] [Full Text] [Related]
16. Chemical castration: MPA treatment of the sexual offender.
Fitzgerald EA
Am J Crim Law; 1990; 18(1):1-60. PubMed ID: 15991431
[No Abstract] [Full Text] [Related]
17. [The question of intermittent hormonal treatment of cancer of the prostate].
Boca P
Acta Urol Belg; 1998 May; 66(2):17-20. PubMed ID: 9633121
[No Abstract] [Full Text] [Related]
18. Experimental interventions with sex offenders: a brief review of their efficacy.
Crighton D; Towl G
Evid Based Ment Health; 2007 May; 10(2):35-7. PubMed ID: 17459969
[No Abstract] [Full Text] [Related]
19. Androgen deprivation before prostate radiotherapy: how long is long enough?
Parker C
Lancet Oncol; 2011 May; 12(5):411-2. PubMed ID: 21440506
[No Abstract] [Full Text] [Related]
20. The role of intermittent androgen deprivation in prostate cancer.
Boccon-Gibod L; Hammerer P; Madersbacher S; Mottet N; Prayer-Galetti T; Tunn U
BJU Int; 2007 Oct; 100(4):738-43. PubMed ID: 17662079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
